| 套细胞淋巴瘤的治疗进展 |
| |
| 引用本文： | 李晶,刘爱春. 套细胞淋巴瘤的治疗进展[J]. 现代肿瘤医学, 2014, 0(8): 1990-1993. DOI: 10.3969/j.issn.1672-4992.2014.08.76 |
| |
| 作者姓名： | 李晶 刘爱春 |
| |
| 作者单位： | 哈尔滨医科大学附属第三医院血液淋巴内科，黑龙江 哈尔滨 150086 |
| |
| 摘 要： | 套细胞淋巴瘤(mantle cell lymphoma,MCL)是来源于相对成熟的B淋巴细胞的特殊淋巴瘤亚型，兼具惰性淋巴瘤的难治愈性以及侵袭性淋巴瘤的缓解期短的特征。同时具有独特的生物学、病理学、免疫表型。如不行造血干细胞移植，目前尚无有效的治愈方法，预后较差。近年，新的靶向药物不断研发和临床应用，给MCL的治疗提供更多的选择，同时很大的改善了治疗效果。
|
| 关 键 词： | 套细胞淋巴瘤 靶向治疗 抗肿瘤新药 |
Recent advances in the management of mantle cell lymphoma |
| |
| Li Jing,Liu Aichun. Recent advances in the management of mantle cell lymphoma[J]. Journal of Modern Oncology, 2014, 0(8): 1990-1993. DOI: 10.3969/j.issn.1672-4992.2014.08.76 |
| |
| Authors: | Li Jing Liu Aichun |
| |
| Affiliation: | Department of Blood Lymph Medicine,The Third Affiliated Hospital of Harbin Medical University,Heilongjiang Harbin 150086,China. |
| |
| Abstract: | Mantle cell lymphoma（MCL）is a specific subtype of mature B cells lymphoma,which characterized by refractoriness of indolent lymphoma and shorter remission of aggressive lymphoma. It own particular biology,pathology and immunophenotype. it is considered incurable without henmotapoietic stem cell transplantation and a dismal prog-nosis. Recently,along with novel treatment options have entered the clinical arena,provided more strategies to choose and improve therapeutic effect. |
| |
| Keywords: | mantle cell lymphom targeted therapy antitumor drugs |
| 本文献已被 维普 等数据库收录！ |
| 点击此处可从《现代肿瘤医学》浏览原始摘要信息 |
|
点击此处可从《现代肿瘤医学》下载免费的PDF全文 |
